RAPT Therapeutics
RAPT
#5939
Rank
A$1.53 B
Marketcap
A$55.30
Share price
4.31%
Change (1 day)
383.65%
Change (1 year)

Earnings for RAPT Therapeutics (RAPT)

Earnings in 2025 (TTM): -A$0.18 Billion

According to RAPT Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.21 Billion a decrease over its 2023 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for RAPT Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-13.25%
2024 -A$0.21 Billion7.11%
2023 -A$0.2 Billion48.1%
2022 -A$0.13 Billion23.97%
2021 -A$0.11 Billion30.06%
2020 -A$79.97 Million21.96%
2019 -A$65.57 Million18.1%
2018 -A$55.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 31.42%๐Ÿ‡บ๐Ÿ‡ธ USA